Jack Junjie Chan (Jack J Chan, Jack Chan)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 12

Top Venues

Journal of gynecologic oncology

NPJ breast cancer

Therapeutic advances in medical oncology

Science advances

National Cancer Centre Singapore

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National Cancer Centre Singapore Sep 01 2017

Singapore

Consultant :: Division of Medical Oncology

Publications

Daniel Jia Ming Ang, Jack Junjie Chan
Evolving standards and future directions for systemic therapies in cervical cancer. Journal of gynecologic oncology 35 (2) (2024)
Daniel Jia Ming Ang, Jack Junjie Chan
Evolving standards and future directions for systemic therapies in cervical cancer. Journal of gynecologic oncology 35 (2) (2024)
Daniel Jia Ming Ang, Jack Junjie Chan
Evolving standards and future directions for systemic therapies in cervical cancer. Journal of gynecologic oncology 35 (2) (2024)
Daniel Jia Ming Ang, Jack Junjie Chan
Evolving standards and future directions for systemic therapies in cervical cancer. Journal of gynecologic oncology 35 (2) (2024)
Daniel Jia Ming Ang, Jack Junjie Chan
Evolving standards and future directions for systemic therapies in cervical cancer. Journal of gynecologic oncology (2024)
Daniel Jia Ming Ang, Jack Junjie Chan
Evolving standards and future directions for systemic therapies in cervical cancer. Journal of gynecologic oncology 35 (2) (2024)
Jun Ma, Jack Junjie Chan, Ching Han Toh, Yoon Sim Yap
Emerging systemic therapy options beyond CDK4/6 inhibitors for hormone receptor-positive HER2-negative advanced breast cancer. NPJ breast cancer 9 (1) (2023)
Suthinee Ithimakin, Napa Parinyanitikul, Sung-Bae Kim, Yoon Sim Yap, Janice Tsang, Inda S Soong, Yukinori Ozaki, Sumito Saeki, Makiko Ono, Jack Junjie Chan, Hung Chun Skye Cheng, Thitiya Dejthevaporn, null null
Disparities in Access to Systemic Treatment for Breast Cancer in Thailand and Major Asian Territories. Journal of breast cancer 25 (3) (2022)
Ser Yue Loo, Li Ping Toh, William Haowei Xie, Elina Pathak, Wilson Tan, Siming Ma, May Yin Lee, S Shatishwaran, Joanna Zhen Zhen Yeo, Ju Yuan, Yin Ying Ho, Esther Kai Lay Peh, Magendran Muniandy, Federico Torta, Jack Junjie Chan, Tira Jing Ying Tan, Yirong R Sim, Veronique Kiak Mien Tan, Kiat Tee Benita Tan, Preetha Madhukumar, Wei Sean Yong, Kong Wee Ong, Chow Yin Wong, Puay Hoon Tan, Yoon Sim Yap, Lih-Wen Deng, Rebecca A Dent, Roger Sik Yin Foo, Markus R Wenk, Soo-Chin Lee, Ying Swan Ho, Elaine Hsuen Lim, Wai Leong Tam
Fatty acid oxidation is a druggable gateway regulating cellular plasticity for driving metastasis in breast cancer. Science advances 7 (41) (2021)
David Shao Peng Tan, Jack Junjie Chan, Robert Hettle, Wrik Ghosh, Amrita Viswambaram, Cindy Chen Yu
Cost-effectiveness of olaparib versus routine surveillance in the maintenance setting for patients with BRCA-mutated advanced ovarian cancer after response to first-line platinum-based chemotherapy in Singapore. Journal of gynecologic oncology 32 (2) (2021)
Jack Junjie Chan, Yirong Sim, Samuel Guan Wei Ow, Joline Si Jing Lim, Grace Kusumawidjaja, Qingyuan Zhuang, Ru Xin Wong, Fuh Yong Wong, Veronique Kiak Mien Tan, Tira Jing Ying Tan
The impact of COVID-19 on and recommendations for breast cancer care: the Singapore experience. Endocrine-related cancer 27 (9) (2020)
Jack Junjie Chan, Tira J Y Tan, Rebecca A Dent
Novel therapeutic avenues in triple-negative breast cancer: PI3K/AKT inhibition, androgen receptor blockade, and beyond. Therapeutic advances in medical oncology 11 (2019)

Jack Junjie Chan.css-eqlu8i{font-size:small;padding-left:4px;} (Jack J Chan, Jack Chan)

Publication Activity (10 Years)

Top Topics

Top Venues

Jack Junjie Chan (Jack J Chan, Jack Chan)